Literature DB >> 26538533

Barriers to guideline-compliant psoriasis care: analyses and concepts.

L Eissing1, M A Radtke1, N Zander1, M Augustin1.   

Abstract

Despite the availability of effective therapeutics and evidence-based treatment guidelines, a substantial proportion of patients with moderate-to-severe psoriasis does not receive appropriate care. This under-provision of health care may cause further worsening of health, remarkable limitations of the patient's quality of life, and indirect costs for the health care system. In order to provide guideline-compliant care for every psoriasis patient, it is important to identify barriers obstructing optimal care. Studies have identified various barriers on the physician's and on the patient's side; however, respective studies approached only single barriers, and not all of them in the context of psoriasis. Other publications that describe barriers systematically did not focus on psoriasis either. The objective of this literature review was to identify barriers and facilitators, based on studies analysing quality of care and single barriers, resulting in a comprehensive model of causal factors. Our analyses revealed three categories of barriers - patient-related, physician-related and external factors: On the patient side, we found non-adherence to therapies to be an important barrier, often in close association with psychiatric factors. Barriers on the physician's side predominantly are incomplete knowledge of the guidelines as well as the complexity of psoriasis comorbidity. In some countries, payment for patients with complex disease status is poor and inconsistent reimbursement regulations potentially interfere with optimal care. The current analysis indicates that most barriers are interdependent. Thus, measures approaching related barriers simultaneously are required. To improve care for psoriasis patients, further studies systematically addressing all potentially relevant barriers in conjoint are needed.
© 2015 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2015        PMID: 26538533     DOI: 10.1111/jdv.13452

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  11 in total

Review 1.  [Regional variations in healthcare for patients with psoriasis and atopic dermatitis in Germany].

Authors:  M Augustin; C Garbe; S Neitemeier; T Steimle; S Schwarz; J Augustin; R von Kiedrowski; K Hagenström
Journal:  Hautarzt       Date:  2021-11-25       Impact factor: 0.751

2.  Prescription Behaviour and Barriers to Prescription of Biologicals for Treatment of Chronic Inflammatory Skin Diseases in Dermatological Practice in Two German Federal States.

Authors:  Daniela Weiss; Imke Nordhorn; Linda Tizek; Thomas Werfel; Alexander Zink; Tilo Biedermann; Stephan Traidl; Maximilian C Schielein
Journal:  Acta Derm Venereol       Date:  2021-09-28       Impact factor: 3.875

3.  Patients' and Doctors' Beliefs about Treatment and Long-Term Adherence in Rheumatic Diseases.

Authors:  John Yfantopoulos; Marianna Protopapa; Konstantinos Mantalias; Athanasios Chantzaras; Katerina Koutsogianni; Platonas Yfantopoulos; Dimitrios Vassilopoulos
Journal:  Mediterr J Rheumatol       Date:  2020-06-11

4.  [Health care of chronic inflammatory skin diseases : Do affected individuals seek dermatological care?]

Authors:  M C Schielein; L Tizek; F Seifert; T Biedermann; A Zink
Journal:  Hautarzt       Date:  2019-11       Impact factor: 0.751

5.  Topical medication utilization and health resources consumption in adult patients affected by psoriasis: findings from the analysis of administrative databases of local health units.

Authors:  Valentina Perrone; Diego Sangiorgi; Stefano Buda; Luca Degli Esposti
Journal:  Clinicoecon Outcomes Res       Date:  2017-03-06

6.  Doctors' views and strategies to improve patients' adherence to medication.

Authors:  John Yfantopoulos; Marianna Protopapa; Athanasios Chantzaras; Platonas Yfantopoulos
Journal:  Hormones (Athens)       Date:  2021-04-29       Impact factor: 2.885

Review 7.  The German National Program on Psoriasis Health Care 2005-2015: results and experiences.

Authors:  M Augustin; L Eissing; A Langenbruch; A Enk; T Luger; D Maaßen; U Mrowietz; K Reich; M Reusch; K Strömer; D Thaçi; R von Kiedrowski; M A Radtke
Journal:  Arch Dermatol Res       Date:  2016-04-05       Impact factor: 3.017

Review 8.  Barriers to treatment: describing them from a different perspective.

Authors:  Francesca Devine; Taylor Edwards; Steven R Feldman
Journal:  Patient Prefer Adherence       Date:  2018-01-17       Impact factor: 2.711

9.  Always Online? Internet Addiction and Social Impairment in Psoriasis across Germany.

Authors:  Maximilian Christian Schielein; Linda Tizek; Barbara Schuster; Stefanie Ziehfreund; Claudia Liebram; Kilian Eyerich; Alexander Zink
Journal:  J Clin Med       Date:  2020-06-11       Impact factor: 4.241

Review 10.  Alcohol in Psoriasis-From Bench to Bedside.

Authors:  Zita Szentkereszty-Kovács; Krisztián Gáspár; Andrea Szegedi; Lajos Kemény; Dóra Kovács; Dániel Törőcsik
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.